Y-mAbs Therapeutics, Inc. (YMAB)
NASDAQ: YMAB · Real-Time Price · USD
8.59
-0.02 (-0.23%)
Sep 15, 2025, 4:22 PM EDT - Market open
Y-mAbs Therapeutics Market Cap
Y-mAbs Therapeutics has a market cap or net worth of $390.32 million as of September 16, 2025. Its market cap has decreased by -43.10% in one year.
Market Cap
390.32M
Enterprise Value
332.06M
1-Year Change
-43.10%
Ranking
Category
Stock Price
$8.59
Market Cap Chart
Since September 21, 2018, Y-mAbs Therapeutics's market cap has decreased from $796.74M to $390.32M, a decrease of -51.01%. That is a compound annual growth rate of -9.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 391.22M | 11.56% |
| Dec 31, 2024 | 350.70M | 17.88% |
| Dec 29, 2023 | 297.50M | 39.61% |
| Dec 30, 2022 | 213.10M | -69.88% |
| Dec 31, 2021 | 707.47M | -64.73% |
| Dec 31, 2020 | 2.01B | 61.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 21, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |